The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| AWH | -85.46% | -99.05% | -60.59% | -100% |
| S&P | +16.23% | +94.45% | +14.22% | +369% |
Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $2.40M | -0.8% |
| Gross Profit | $1.53M | 8.0% |
| Gross Margin | 63.81% | 5.2% |
| Market Cap | $4.41M | -76.3% |
| Market Cap / Employee | $0.07M | 0.0% |
| Employees | 66 | 3.1% |
| Net Income | -$2.67M | 24.5% |
| EBITDA | -$1.80M | 58.8% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $1.55M | 60.6% |
| Accounts Receivable | $1.28M | -11.6% |
| Inventory | 0.3 | 20.8% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $2.28M | 34.1% |
| Short Term Debt | $0.53M | -20.2% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -212.57% | 60.6% |
| Return On Invested Capital | 7626.27% | 7108.8% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$1.73M | 53.8% |
| Operating Free Cash Flow | -$1.73M | 53.6% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | -2.80 | -4.56 | -0.64 | -85.94 | 536.89% |
| Price to Sales | 1.39 | 1.28 | 0.22 | 0.56 | -73.24% |
| Price to Tangible Book Value | -2.80 | -4.56 | -0.64 | -85.79 | 535.72% |
| Enterprise Value to EBITDA | -3.36 | -3.92 | -0.55 | -3.59 | -21.82% |
| Return on Equity | -701.3% | - | |||
| Total Debt | $2.14M | $3.38M | $3.06M | $2.81M | 18.94% |
AWH earnings call for the period ending June 30, 2022.
AWH earnings call for the period ending December 31, 2021.
AWH earnings call for the period ending September 30, 2021.
AWH earnings call for the period ending June 30, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
